EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1 Reporter for Stable Red Fluorescence

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic mRNA encoding the red fluorescent protein mCherry, engineered with a Cap 1 structure to enhance translation efficiency and mimic mammalian mRNA capping (ApexBio R1017 product page). It incorporates 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) to suppress innate immune detection and increase mRNA stability (Guri-Lamce et al., 2024). The mRNA is ~996 nucleotides long and supplied at ~1 mg/mL in 1 mM sodium citrate buffer, pH 6.4. Applications include use as a robust molecular marker for fluorescent protein expression and precise cell component localization. Correct storage at ≤ -40°C is required to maintain integrity and activity.

Biological Rationale

Messenger RNA (mRNA) is widely used as a vehicle for gene delivery and reporter assays due to its direct translation capabilities and non-integrating nature (Guri-Lamce et al., 2024). The mCherry protein is a monomeric red fluorescent protein derived from DsRed of Discosoma sp., with a mature emission peak at 610 nm and excitation maximum at 587 nm, making it suitable for multiplexed imaging (FPbase, mCherry). Cap 1 structure on eukaryotic mRNA, characterized by methylation at the 2'-O position of the first nucleotide, increases translation efficiency and reduces innate immune sensing (Schuberth-Wagner et al., Nature 2010). Incorporation of nucleotide analogs such as 5mCTP and ψUTP further decreases activation of pattern recognition receptors like TLR7 and RIG-I, improving mRNA tolerance and persistence (Guri-Lamce et al., 2024). A poly(A) tail supports ribosome recruitment and efficient translation initiation (NCBI Bookshelf: mRNA Processing).

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is synthesized in vitro and capped enzymatically using Vaccinia virus Capping Enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2'-O-Methyltransferase to generate a Cap 1 structure. This capping mimics endogenous mammalian mRNA, protecting against exonucleolytic degradation and facilitating efficient ribosomal recognition. The modified nucleotides—5mCTP and ψUTP—are incorporated during transcription to minimize recognition by innate immune sensors, which would otherwise trigger mRNA decay and inflammatory responses (Guri-Lamce et al., 2024). Translation of the mRNA in eukaryotic cells yields the mCherry protein, which fluoresces in the red channel and is used as a molecular marker for gene expression and localization studies. The included poly(A) tail enhances stability and translation by interacting with poly(A)-binding proteins.

Evidence & Benchmarks

• Lipid nanoparticle (LNP)-packaged mRNA with Cap 1 and nucleotide modifications achieves efficient cytoplasmic delivery and reporter expression in fibroblast cell models (Guri-Lamce et al., 2024, DOI).
• 5mCTP and ψUTP modifications reduce TLR7 and RIG-I mediated innate immune activation, as shown by suppressed type I interferon responses in vitro (DOI).
• Cap 1 mRNA is translated more efficiently than Cap 0 mRNA in mammalian systems, leading to higher protein output under identical conditions (Schuberth-Wagner et al., Nature 2010).
• mCherry mRNA at 1 mg/mL in sodium citrate buffer remains stable for >6 months at ≤ -40°C, with minimal degradation as confirmed by agarose gel electrophoresis (ApexBio R1017 product page).
• Fluorescence intensity of mCherry translates linearly with mRNA dose in mammalian cell models, permitting quantitative imaging (internal review).

Applications, Limits & Misconceptions

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is optimized for use as a reporter in transfection assays, live-cell imaging, and molecular mapping. Its immune-evasive properties make it suitable for primary cells and sensitive cell lines. The product is not intended for therapeutic use in humans or in vivo gene therapy. The mRNA does not integrate into the host genome and expression is transient, typically lasting several days depending on cell turnover and degradation rates.

Compared to conventional mCherry expression plasmids, this mRNA enables faster onset of protein expression and avoids integration risks. For an in-depth mechanistic overview, see Redefining Reporter Gene Paradigms; this article extends that analysis by presenting recent evidence for Cap 1 and modified nucleotide synergy.

Common Pitfalls or Misconceptions

• EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is not a gene therapy reagent and is not suitable for permanent genetic modification.
• Expression duration is limited (typically 2–5 days); it does not ensure stable integration or long-term expression.
• mRNA stability is compromised if storage temperature exceeds -40°C or if repeated freeze-thaw cycles occur.
• This product does not confer antibiotic resistance or selection markers; it is a reporter only.
• The emission/excitation wavelengths (610/587 nm) may overlap with other red fluorophores; spectral compensation may be required for multiplex imaging.

For further discussion of practical limits in cell imaging workflows, see EZ Cap™ mCherry mRNA: Advanced Cap 1 Reporter; the present article clarifies the immune evasion mechanisms and storage stability benchmarks.

Workflow Integration & Parameters

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is delivered at ~1 mg/mL in 1 mM sodium citrate buffer, pH 6.4. For optimal transfection, use lipid-based delivery agents such as LNPs or Lipofectamine MessengerMAX. Typical working concentrations range from 10–500 ng per well (24-well plate), adjusted to application and cell type. The mRNA should be aliquoted and stored at ≤ -40°C. Avoid more than three freeze-thaw cycles to preserve integrity.

Expression can be quantified by fluorescence microscopy or flow cytometry. The mCherry protein encoded is 236 amino acids in length, with a molecular weight of ~26.7 kDa. For a practical guide to integrating this reagent with multicolor reporter workflows, see mCherry mRNA with Cap 1: Next-Gen Reporter Gene; this article updates those recommendations with the latest stability data.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) sets a new standard for reporter gene mRNA design by combining Cap 1 capping with 5mCTP and ψUTP modifications. This approach delivers robust, immune-evasive, and stable red fluorescence in cell-based assays. As mRNA technologies advance, such reagents will underpin the next generation of molecular markers for cell component localization and high-content imaging. See the full product details for EZ Cap™ mCherry mRNA (5mCTP, ψUTP) (SKU: R1017).